Myeloid Leukemia Therapy
Data from University of Massachusetts advance knowledge in myeloid leukemia therapy
Published in Blood Weekly, February 18th, 2010
Scientists discuss in 'The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia' new findings in myeloid leukemia. "Cancer stem cells (CSCs) are believed to be the initiating cells for many types of blood cancer and some solid tumors, and curative therapies of these cancers require eradicating CSCs. Specific targeting of CSCs but not normal stem cell counterparts is a correct strategy for developing new anti-cancer therapies, and the success of this approach relies on identification of specific target genes in CSCs," researchers in the United States report.
"Using BCR-ABL-induced chronic myeloid leukemia (CML) as a cancer model, we...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-02-18)
More Articles from Blood Weekly
- Cell Transplantation Center of Excellence for Aging and Brain Repair
Beyond liver transplants: Acutely damaged livers may be repaired via transplanted hepatocytes - Johns Hopkins Medical Institutions
3 years out, safety checklist continues to keep hospital infections in check - Stowers Institute for Medical Research
Linheng Li proposes novel theory for mammalian stem cell regulation - Tufts University, Health Sciences
Cell of origin identified for common type of breast cancer - University of Michigan
Mechanical forces could affect gene expression - Wiley-Blackwell
Heart attack victims who have ECGs in the field experience shorter time-to-treatment - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
